Oprelvekin is a
**Core Concept**
Oprelvekin, also known as interleukin-11 (IL-11), is a thrombopoietic growth factor used in the treatment of thrombocytopenia. It stimulates the production of platelets by acting on megakaryocytes, a type of bone marrow cell responsible for platelet production.
**Why the Correct Answer is Right**
Oprelvekin works by binding to the interleukin-11 receptor on the surface of megakaryocytes, triggering a signaling cascade that increases platelet production and release into the bloodstream. This process is crucial in patients with thrombocytopenia, a condition characterized by low platelet counts, which can increase the risk of bleeding.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because Oprelvekin is not an anticoagulant, which is a medication used to prevent or treat blood clots.
**Option B:** Incorrect because Oprelvekin is not an antiplatelet agent, which is a medication used to prevent platelet aggregation and reduce the risk of thrombotic events.
**Option C:** Incorrect because Oprelvekin is not a recombinant erythropoietin, which is a medication used to stimulate red blood cell production in patients with anemia.
**Clinical Pearl / High-Yield Fact**
Oprelvekin is an example of a thrombopoietic growth factor, which stimulates platelet production in the bone marrow. This class of medications is used to treat thrombocytopenia and is particularly useful in patients undergoing chemotherapy or stem cell transplantation.
**Correct Answer:** B. Interleukin-11 (IL-11) growth factor.